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Abstract 14 
Clostridium difficile spore germination is essential for colonization and disease. The signals that 15 
initiate C. difficile spore germination are a combination of taurocholic acid (a bile acid) and 16 
glycine. Interestingly, the chenodeoxycholic acid-class (CDCA) bile acids competitively inhibit 17 
taurocholic acid-mediated germination suggesting that compounds that inhibit spore germination 18 
could be developed into drugs that prophylactically prevent C. difficile infection or reduce 19 
recurring disease. However, a recent report called into question the utility of such a strategy to 20 
prevent infection by describing C. difficile strains that germinated in the apparent absence of bile 21 
acids or germinated in the presence of the CDCA inhibitor. Because the mechanisms of C. 22 
difficile spore germination are beginning to be elucidated, the mechanism of germination in these 23 
particular strains could yield important information on how C. difficile spores initiate 24 
germination. Therefore, we quantified the interaction of these strains with  taurocholic acid and 25 
CDCA, the rates of spore germination, the release of DPA from the spore core and the 26 
abundance of the germinant receptor complex (CspC, CspB and SleC). We find that strains 27 
previously observed to germinate in the absence of taurocholic acid demonstrate more potent 28 
EC50,TA values towards the germinant and are still inhibited by CDCA, possibly explaining the 29 
previous observations. By comparing the germination kinetics and the abundance of proteins in 30 
the germinant receptor complex, we revise our original model for CspC-mediated activation of 31 
spore germination and propose that CspC may activate spore germination and then inhibit 32 
downstream processes. 33 
 34 
Importance 35 
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Clostridium difficile forms metabolically dormant spores that persist in the healthcare 36 
environment. In susceptible hosts, C. difficile spores germinate in response to certain bile acids 37 
and glycine. Blocking germination by C. difficile spores is an attractive strategy to prevent the 38 
initiation of disease or to block recurring infection. However, certain C. difficile strains have 39 
been identified whose spores germinate in the absence of bile acids or are not blocked by known 40 
inhibitors of C. difficile spore germination (calling into question the utility of such strategies). 41 
Here, we further investigate these strains and re-establish that bile acid activators and inhibitors 42 
of germination affect these strains and use this data to suggest another role for the C. difficile bile 43 
acid germinant receptor. 44 
 45 
Introduction 46 
Spore formation and germination by Peptoclostridium difficile spores (1) (referred herein as 47 
Clostridium difficile for simplicity) are significant hurdles for overcoming the transmission of 48 
this pathogen within the hospital environment. Due to the strict anaerobic nature of C. difficile 49 
vegetative cells, spores are thought to be the main reservoir for transmission within the 50 
healthcare setting (2, 3). Prior antibiotic treatment is the greatest risk factor for C. difficile 51 
infection (4). Broad-spectrum antibiotics alter the balance of the colonic microbiota allowing C. 52 
difficile an opportunity to colonize the newly generated niche (5-7). Once in a host, C. difficile 53 
spores germinate to form the toxin-producing vegetative cells that colonize a host’s colonic 54 
environment. In susceptible hosts, C. difficile vegetative cells secrete two toxins that damage the 55 
colonic epithelium and lead to the primary symptoms of disease (8, 9). C. difficile infections are 56 
commonly treated with more antibiotics (e.g., metronidazole, vancomycin or fidaxomicin) (10). 57 
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After disease symptoms are alleviated and the antibiotics are discontinued, patients frequently 58 
relapse with recurring disease due to germination by spores that remain in the colon or that re-59 
infect the host from the surrounding environment (10). Because germination by the spore form is 60 
required for pathogenesis, compounds that prevent spore germination could be an attractive way 61 
to prevent the primary or recurring infections (11-13). 62 
 Endospores are dormant forms of bacteria and are formed by vegetative cells in response 63 
to environmental stress (14, 15). In Bacillus subtilis, sporulation is a tightly regulated process 64 
and involves the formation of a forespore within a mother cell (16). The forespore and mother 65 
cell communicate through a cascade of sigma factor activation and waves of 66 
transcription/translation (16). The end result of this developmental program is a dormant spore 67 
consisting of a DNA-containing core where much of the water has been replaced by dipicolinic 68 
acid as a calcium chelate (CaDPA) (17). Surrounding the spore core is an inner spore membrane, 69 
a thin germ-cell peptidoglycan layer, a thick cortex peptidoglycan layer, an outer spore 70 
membrane and layers of coat protein (15). The coat proteins, cortex and the contents of the 71 
desiccated core help protect the spore from environmental stressors (e.g., heat, radiation, 72 
chemicals and antibiotics) and keep the spore in a metabolically dormant state (15, 17). 73 
 Endospore germination has been extensively studied in B. subtilis (15). In B. subtilis, 74 
spore germination can be initiated when L-alanine (a germinant) interacts with the GerAA-AB-75 
AC germinant receptor which is embedded within the inner spore membrane (15). This 76 
interaction triggers the release of the large depot of CaDPA, presumably through the SpoVA 77 
membrane channel (15). This results in the partial hydration of the spore’s core. As CaDPA 78 
passes through the cortex layer, CaDPA activates the CwlJ cortex hydrolase and the actions of 79 
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the CwlJ and SleB hydrolases degrade the spore cortex resulting in core expansion and full 80 
rehydration of the spore core (15).  81 
 The receptors with which spore germinants interact are conserved between most of the 82 
studied spore-forming bacteria (e.g., B. subtilis, B. anthracis and C. perfringens) while the 83 
germinants which activate spore germination vary between organisms (but germinants are 84 
generally amino acids, nucleotides, ions or sugars) (18). C. difficile spore germination is initiated 85 
by certain bile acids (presumably a host signal) and glycine (presumably a nutrient signal) (14, 86 
19-21). Bile acids are small, steroid acids that are released by the gall bladder into the digestive 87 
tract to aid in the absorption of fats and cholesterol (22). Two families of bile acids are 88 
synthesized by the liver: cholic acid-derivatives and chenodeoxycholic acid-derivatives (CDCA). 89 
Each of these families is conjugated with either a taurine [taurocholic acid (TA) or 90 
taurochenodeoxycholic acid] or a glycine (glycocholic acid or glycochenodeoxycholic acid) (22). 91 
C. difficile spore germination is stimulated by cholic acid while CDCA-derivatives inhibit cholic 92 
acid-mediated germination (11, 19, 23, 24). Based on previous studies, C. difficile spores have an 93 
EC50 value (the concentration that achieves half-maximum germination rate) in the low 94 
millimolar range for TA and the high micromolar range for CDCA, suggesting that C. difficile 95 
spores may have a tighter interaction with inhibitors of germination than with the activators of 96 
germination (11, 23-25). 97 
Though the signals that stimulate spore germination have been studied for some time, 98 
only recently was the receptor with which the bile acids interact identified (13). C. difficile does 99 
not encode the classical, membrane-embedded, ger-type, germinant receptor (26). Instead, C. 100 
difficile spore germination proceeds through a novel germination pathway involving direct 101 
stimulation of cortex hydrolysis and subsequent release of CaDPA from the spore core (opposite 102 
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to what is observed for germinant receptor-mediated germination in B. subtilis or Clostridium 103 
perfringens) (13-15, 27, 28). In our working model, C. difficile spore germination is initiated 104 
when the germination-specific, pseudoprotease, CspC, interacts with the cholic acid-class of bile 105 
acids (13). Activated CspC transmits the bile acid activating signal to the CspB protease which 106 
then activates the spore cortex lytic enzyme SleC (deposited in the spore as a zymogen) (13, 29). 107 
Activated SleC then begins to degrade the spore cortex and CaDPA is subsequently released 108 
from the spore core (27, 28).  109 
Based on the model described above, all C. difficile isolates should have the requirement 110 
for bile acids to stimulate germination. Indeed, spores derived from most clinical isolates require 111 
taurocholic acid (TA) to initiate spore germination in rich medium (30, 31). However, a few 112 
isolates have been reported not to require TA as a spore germinant or not to be inhibited the 113 
CDCA anti-germinant (31). If these strains have no requirement for TA or are not inhibited by 114 
CDCA, by what mechanism would they be activated for germination (i.e., would the 115 
mechanisms for germination in these strains be different from what has been described 116 
previously)? 117 
Here we aimed to re-examine the germination of spores derived from C. difficile strains 118 
that were reported previously to germinate in rich medium alone or germinate in the presence of 119 
a known inhibitor of C. difficile spore germination, CDCA (31), and compare this germination to 120 
that of spores that clearly require TA for germination (11, 25, 27, 32). Upon reinvestigation of 121 
these strains, we find that strains previously thought not to be inhibited by CDCA are actually 122 
inhibited by CDCA and interact with CDCA with similar inhibitor constant values as other 123 
strains. However, these strains do exhibit greater EC50,TA values, possibly explaining previous 124 
observations (31). We further characterize these strains by determining the abundance of the 125 
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germinant receptor complex and show that the levels of CspC, CspB and SleC differ between 126 
strains. By comparing the generated kinetic data with the abundance of spore proteins, we revise 127 
our model for the mechanism of initiating C. difficile spore germination.  Based on our prior 128 
genetic data and the data herein, we propose that CspC acts to initiate spore germination in the 129 
presence of TA but then to inhibit downstream processes until another signal is received. 130 
 131 
Materials and Methods 132 
Strains and growth conditions 133 
C. difficile strains (Table S1) were grown in a Model B, Coy Laboratories anaerobic chamber 134 
(10% H2, 5% CO2, 85% N2) at 37 °C in Brain Heart Infusion supplemented with 5 g / L yeast 135 
extract and 0.1% L-cysteine (BHIS), as described previously (13, 27, 32, 33). Escherichia coli 136 
routinely was grown at 37 °C in LB medium or in 2xTY medium (5 g NaCl, 10 g yeast extract, 137 
16 g tryptone / L) for protein expression (see below). Antibiotics were supplemented as needed 138 
(100 μg / mL ampicillin). 139 
Molecular Biology 140 
The C. difficile UK1 sleC gene was amplified with Phusion DNA polymerase (New England 141 
Biolabs, Beverly, MA) using primers 5’pET_SleC 142 
(TTTTGTTTAACTTTAAGAAGGAGATATACATATGCAAGATGGTTTCTTAACAGTAAG143 
C) and 3’pET_SleC 144 
(ATCTCAGTGGTGGTGGTGGTGGTGCTCGAGAATTAAAGGATTTAAAGAAGCTATT). 145 
The resulting PCR product was inserted into pET22b between the XhoI and NdeI restriction sites 146 
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using Gibson Assembly (34) and transformed into E. coli DH5α to generate pKS08. To construct 147 
a strain producing CspB for recombinant protein expression, the cspB gene was amplified with 148 
Phusion DNA polymerase from C. difficile UK1 genomic DNA with primers 5’CO_cspB 149 
(GTTTAACTTTAAGAAGGAGATATACATATGATTATCATTAATTACGAACTGATTGTG150 
AAG) and 3’CO_cspB_CPD (TTCCATCCGCGAGCTCGCTTTTATTAATGCTGCG). To aid 151 
in solubility and allow for the generation of an un-tagged CspB protein, the cysteine protease 152 
domain from the Vibrio cholerae MARTX protease (CPD) was fused to the 3’end of cspB (35). 153 
cpd was amplified from the pcspC-CO-Δ50CPD plasmid using primers 5’CPD_cspB 154 
(CGCAGCATTAATAAAAGCGAGCTCGCGGATGGAA) and 3’CPD_pET 155 
(ATCTCAGTGGTGGTGGTGGTGGTGCTCGAGACCTTGCGCGTCCCA). The resulting 156 
cspB and cpd PCR products were inserted into pET22b between restriction sites XhoI and NdeI 157 
using Gibson Assembly (34) and the resulting plasmid was named pKS02. The C. difficile cspC 158 
gene was codon optimized for expression in E. coli (Eurofins Genomics, Ebersberg, Germany). 159 
The resulting gene was sub-cloned into pET22b-CPD (35). The sequences of all inserts were 160 
verified.  161 
Spore preparation 162 
Spores were generated and purified as described previously (13, 25, 27, 32). Briefly, C. difficile 163 
strains were streaked onto 10 – 15 plates of BHIS agar medium. After 4 days, the growth from 164 
each plate was scraped into 1 mL sterile water and incubated overnight at 4 °C. The following 165 
day, the growth suspension was washed 5 times in sterile water. During each wash step, the layer 166 
of white cell debris was removed. After washing, the spores/cell debris were suspended in 25% 167 
(w/v) HistoDenz (Sigma Aldrich, St. Louis, MO.) and layered onto a 50% (w/v) HistoDenz 168 
solution. The resulting gradient was centrifuged at 18,900 x g for 30 minutes. During 169 
 o
n
 Septem
ber 12, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
9 
 
centrifugation, spores migrate through the 50% HistoDenz while the less-dense vegetative cells 170 
and cell debris remain at the interface. After centrifugation, the solution is removed and the 171 
pellet, containing the purified spores, was washed 5 times in sterile water before being 172 
resuspended in a final volume of 1 mL. Purified spores were examined microscopically and were 173 
found to be >99.9% pure and phase-bright (dormant). 174 
Germination 175 
To quantify the interaction between the bile acids and C. difficile spores, purified spores 176 
were heat-activated at 65 °C for 30 min and then placed on ice. Ten microliters of the heat-177 
activated spores were added to a final OD600 of 0.5 in 990 μL BHIS medium alone or medium 178 
supplemented with the indicated concentrations of bile acids and germination was monitored at 179 
600 nm for 15 minutes in a PerkinElmer (Waltham, MA) Lambda25 UV/Vis Spectrophotometer. 180 
The data points at OD600 (Tx) were normalized to the starting OD600 value (T0). Germination 181 
rates and EC50 values were calculated using the slopes of the linear portions of the germination 182 
plots, as described previously (11, 25). The data shown in Figures 1 and 2 are a representative of 183 
three independent experiments (the data cannot be averaged between experiments due to 184 
differences in time points generated by the PerkinElmer spectrophotometer. For transparency, all 185 
germination plots are included Figures S1 – S3.). Rates and EC50 values were individually 186 
calculated from each germination experiment and are reported as averages with the standard 187 
error of the mean.  188 
The release of CaDPA from germinating C. difficile spores was monitored in real time 189 
using terbium fluorescence (36). An opaque, 96-well plate was prepared with 125 μL of 10 mM 190 
Tris (pH 7.5), 150 mM NaCl, 800 μM TbCl3 and 100 mM glycine alone or supplemented with 191 
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10 mM TA, as described previously (27). Heat-activated spores were then sedimented for 1 min 192 
at 14,000 x g and resuspended in an equal volume of water to remove any CaDPA that may have 193 
been released due to auto germinating spores. A 5-μL sample of a spore suspension (OD600 = 60) 194 
was added to each well, and the CaDPA release was monitored in a Molecular Devices 195 
(Sunnydale, CA) Spectramax M3 fluorescence plate reader. CaDPA release was monitored with 196 
the following settings: excitation = 270 nm; emission = 545 nm; cutoff = 420 nm. The CaDPA 197 
release data are reported as the average of 3 independent experiments and error bars represent the 198 
standard error of the mean. 199 
Total DPA content of the spores was determined by suspending 1x105 spores in buffer 200 
and incubating at 95 °C for 30 minutes. The spores were cooled and sedimented for 2 minutes at 201 
14,000 x g. The amount of released DPA was determined as above using terbium fluorescence. 202 
Protein purification 203 
Overnight cultures of the appropriate BL21 (DE3) strains were diluted 1:200 in 2xTY medium 204 
and incubated at 200 rpm and 37 ºC. When an OD600 of 0.6-0.8 was reached, IPTG was added to 205 
250 µM final concentration, and cultures were grown at 16 ºC for 12-14 hr. Subsequently, the 206 
cultures were pelleted at 6,000 rpm and 4 °C for 30 min and then frozen at -80 °C. Cell pellets 207 
were resuspended in LIB1 (50 mM Tris, pH 7.5, 500 mM NaCl, 15 mM imidazole and 10% 208 
glycerol) and lysed by sonication. HisPur Ni-NTA resin (Thermo Scientific) was added to the 209 
clarified supernatants and washed with LIB2 (50 mM Tris, pH 7.5, 300 mM sodium chloride, 30 210 
mM imidazole and 10% glycerol). For SleC6His, the resulting protein was eluted from the Ni-211 
resin in LIB1 supplemented with 500 mM imidazole. For CspB-CPD6His and CspC-CPD6His, all 212 
proteins were cleaved from the CPD tag in LIB1 supplemented with 75 µM (final concentration) 213 
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phytic acid at room temperature for 20 minutes with shaking (4 cleavage reactions were 214 
sufficient to cleave the respective proteins from the CPD tag). The volume of the phytic acid 215 
cleavings was equal to the Ni-beads bed volume. The resulting proteins were analyzed for their 216 
purity SDS-PAGE and Coomassie staining and quantified by NanoDrop.  217 
Protein extraction and Western Blotting 218 
NuPAGE soluble proteins (which include CspB, CspC and SleC) were extracted from 2x109/mL 219 
purified spores as described previously (37). A separate spore extract from 2x109 C. difficile 220 
JSC11 (cspBA::ermB) spores or C. difficile CAA5 (sleC::ermB) spores was also generated. 221 
Standard amounts of NuPAGE-solubilized recombinant proteins (generated above) were added 222 
to a 10% SDS polyacrylamide gel (a standard curve was generated on every gel run). Equal 223 
volume of extract from mutant spores was added to the wells containing the recombinant protein 224 
standard to allow for equal transfer efficiencies between recombinant protein-containing wells 225 
and extract wells. Proteins were separated by SDS-PAGE. After separation, the gels were 226 
transferred overnight at 30v to a low fluorescence polyvinylidene difluoride (PVDF) membrane 227 
(Bio-Rad). Subsequently, the membrane was blocked for 1 hour at room temperature with 10% 228 
dried, skimmed milk in tris-buffered saline (TBS). Each membrane was washed thrice for 15 min 229 
each with TBS containing 0.1 % (v/v) Tween 20 (TBST). The membrane was then incubated at 230 
room temperature with either rabbit anti-CspC, anti-CspB or anti-SleC antibodies. After 231 
incubation with the primary antibody, membranes were washed as above in TBST. The 232 
membranes were then labeled with Alexa Fluor 555®-labeled donkey anti-rabbit IgG (Life 233 
Technologies) in the dark for 2 hours at room temperature. The membranes were again washed 234 
as above but in the dark. Finally, the fluorescent signal on the membranes were detected by 235 
scanning on a GE Typhoon Scanner using the Cy3 setting (appropriate wavelength for Alexa 236 
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Fluor 555®). The resulting scans were quantified using ImageQuantTL 7.0, image analysis 237 
software provided by GE. 238 
Statistical Analyses 239 
Statistical analysis between the calculated EC50,TA or inhibitor constant (CDCA) values was 240 
accomplished with a One-Way Analysis of Variance (ANOVA) with Tukey’s test for multiple 241 
comparisons. A 99% confidence interval was set for significance (p-val < 0.01) 242 
 243 
Results 244 
Taurocholic acid-induced germination by several C. difficile isolates. 245 
There have been recent reports describing heterogeneity of spore germination between C. 246 
difficile strains (30, 31). Some of these strains appeared to germinate in rich medium in the 247 
absence of the TA germinant. Other strains were not inhibited by CDCA (31). This calls into 248 
question the impact bile acids may have on C. difficile infection and the utility of 249 
germination/antigermination-based therapies. While there are undoubtedly differences in 250 
germination responses between C. difficile strains, the lack of inhibition by CDCA and 251 
germination in the absence of TA warranted further investigation.  252 
Germination by C. difficile strains UK1 and M68 have been described previously by our 253 
lab and spore germination by these strains is activated by TA and inhibited by CDCA (25). We 254 
also analyzed germination by C. difficile strains 5108111, DH1834, DH1858, CD2315 255 
(generously provided by Dr. Nigel Minton) and M120. Of these, spores derived from C. difficile 256 
strains 5108111, DH1834 and CD2315 were reported not to be inhibited by CDCA (spore 257 
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germination by DH1858 was inhibited by CDCA) (31).  To quantitate the differences in 258 
germination responses between isolates, we determined the EC50 values  for taurocholic acid and 259 
spores from different C. difficile strains. These types of assays have been useful to determine the 260 
potency of activators and inhibitors of germination (11, 24, 25, 38-40). Though not traditional 261 
enzyme kinetics (spore germination is a multi-enzyme process), these studies can provide a 262 
quantitative measure for the interaction of the bile acids and C. difficile spores. C. difficile spores 263 
were suspended in BHIS medium alone or in medium supplemented with increasing TA 264 
concentrations (2 mM, 5 mM, 10 mM, 20 mM or 50 mM) and germination was monitored at 265 
OD600. These TA concentrations are routinely used by our laboratory to assign EC50 values for 266 
bile acids. As shown in Figure 1 and Figure S1, BHIS medium alone did not stimulate 267 
germination of the 7 strains tested, suggesting a requirement for TA to initiate spore germination 268 
in rich medium. However, when supplemented with increasing concentrations of TA, C. difficile 269 
UK1, M68 and M120 (Figure 1A, 1F and 1G, respectively) exhibited a concentration-dependent 270 
increase in the rate of germination. Interestingly, C. difficile strains 5108111, CD2315, DH1834 271 
and DH1858 achieved near maximum germination rates at the lowest tested TA concentration 272 
(BHIS + 2 mM TA) (Figure 1B – 1E; Figure S1B – S1E).  273 
Because these strains germinated at near maximum rates in the lowest tested TA 274 
concentration, we modified our germination conditions to determine if these strains are capable 275 
of germinating at even lower TA concentrations (Figure S2). When germination by C. difficile 276 
strains 5108111, CD2315, DH1834 and DH1858 were tested at lower TA concentrations, we 277 
observed dose-dependent increases in germination rates. From the newly generated germination 278 
plots, we generated rate curves and EC50,TA values (Table 1). Spores from C. difficile UK1 and C. 279 
difficile M68 generated EC50,TA values similar to those described previously (25). C. difficile 280 
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DH1834, DH1858 and M120 had similar EC50,TA values (3.0, 3.03 and 2.37 respectively) and 281 
these values are similar to UK1 and M68. Interestingly, compared to the other tested strains, C. 282 
difficile 5108111 and CD2315 had a statistically significant increased EC50 values for TA (Table 283 
1) suggesting that spores derived from these strains require less TA to activate spore 284 
germination. 285 
CDCA-dependent inhibition of C. difficile spore germination. 286 
 Because we observed that some C. difficile strains (5108111, CD2315) exhibited a more 287 
potent interation with TA, we tested if there were differences in in the interaction with CDCA. C. 288 
difficile spores were suspended in BHIS medium or BHIS medium supplemented with 1 mM 289 
CDCA and increasing concentrations of TA (2 mM, 5 mM, 10 mM, 20 mM or 50 mM) and 290 
germination was monitored at OD600. CDCA completely inhibited germination of the 2 mM TA 291 
sample for spores derived from all C. difficile strains except C. difficile strain CD2315. 292 
Interestingly, CDCA had less of an effect on germination by C. difficile CD2315 spores (Figure 293 
2C). However, CDCA still affected its ability to respond to TA as a germinant. By comparing 294 
Figure 1C with Figure 2C, germination by C. difficile CD2315 spores clearly is affected by 295 
CDCA. 296 
 Inhibition constants were generated from the curves in Figure 2/S3 and the calculated 297 
EC50,TA (Table 1). C. difficile UK1 spores and C. difficile M68 spores generated similar inhibitor 298 
constant values as previously described (Table 1) (25) and all strains generated values near or 299 
below 0.5 mM. Spores derived from C. difficile 5108111 had the weakest interaction  with 300 
CDCA (0.52 mM; p-val < 0.01) when compared to the other strains. These results suggest that 301 
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CDCA inhibits germination by spores of C. difficile strains previously thought not to be affected 302 
by the inhibitor.  303 
Though germination of all strains was inhibited by CDCA, the effectiveness of the 304 
inhibitor varied. When the inhibition ratio was calculated (the ratio of the EC50,TA and 305 
EC50,CDCA), most strains exhibited a ratio greater than 10, suggesting that germination is strongly 306 
inhibited by CDCA in these strains (Table 1). Germination by C. difficile 5108111 and CD2315 307 
spores was not strongly inhibited by CDCA (the same strains with an increased EC50,TA) (Table 308 
1). Taken together, the results suggest that, though there are differences in the interactions of the 309 
spores with the bile acids, all tested strains are inhibited by CDCA and are activated by TA.  310 
To determine if the observed differences in the interaction of the bile acids with the C. 311 
difficile spores correlated with specific alterations in the CspB, CspA or CspC protein sequences, 312 
we sequenced the cspBAC locus from each strain. (Figure S4 – S6). All ribotype 027 isolates 313 
(UK1, 5108111, DH1834 and DH1858) had identical CspC sequences, while ribotypes 078 314 
(CD2315 and M120) and 017 (M68) had 26 substitutions between them (Figure S4). C. difficile 315 
CD2315 had a P317L substitution that was not present in any of the other tested strains (Figure 316 
S4). The CspB sequence only varied in ribotype 078 strains (Figure S5) with 13 substitutions. 317 
The CspA proteins varied most between the 3 Csp proteins with a total of 42 substitutions 318 
(Figure S6). With the exception of the CD2315 CspCP317L substitution, all substitutions were 319 
consistent between ribotypes. Because substitutions were ribotype-specific but the EC50,TA and 320 
inhibitor constants were not, these results suggest that the observed differences are not due to 321 
specific changes in the CspB, CspA or CspC sequences. 322 
Taurocholic acid is required for C. difficile spore germination 323 
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Previously, germination by C. difficile strains 5108111, DH1834, DH1858 and CD2315 324 
occurred slowly but in the absence of the TA germinant (31). To further investigate the 325 
phenomenon, we utilized an assay which measures the release of CaDPA from the spore core 326 
during germination (CaDPA release is a requirement for spore germination). Because this assay 327 
is (i) based on the detection of fluorescent CaDPA-Tb3+ complexes and not OD and (ii) each well 328 
is mixed prior to analysis, this assay eliminates any chance of spores settling/clumping/localizing 329 
to the center of a well during the 4 hour incubation. C. difficile spores were suspended in 330 
germination buffer supplemented with glycine only (non-germinating conditions) or TA and 331 
glycine (germination-inducing conditions) and Tb3+ fluorescence was monitored for 4 hours 332 
(Figure S7). Spores from all C. difficile strains tested released CaDPA which resulted in Tb3+ 333 
fluorescence when suspended in both TA and glycine. Spores suspended in glycine alone did not 334 
release CaDPA during the 4 hour assay. These results suggest that these strains require TA to 335 
induce germination in combination with glycine and have a low frequency of autogermination. 336 
 The data presented in Figure S7 suggests that all tested strains have a requirement for TA 337 
to stimulate germination in combination with the glycine co-germinant, but not if these strains 338 
require glycine to germinate. Therefore we tested CaDPA release in the absence of glycine 339 
(Figure 3). C. difficile strains UK1 (Figure 3A), 5108111 (Figure 3B), DH1834 (Figure 3D), 340 
DH1858 (Figure 3E), M68 (Figure 3F) and M120 (Figure 3G) all required the presence of both 341 
TA and glycine to germinate. Interestingly, C. difficile CD2315 (Figure 3C) slowly, but 342 
significantly, germinated in the presence of TA alone. However, germination by CD2315 spores 343 
was enhanced strongly by the presence of glycine (Figure 3C). These results suggest that glycine 344 
is a co-germinant for spores of the tested strains but that C. difficile CD2315 spores can release 345 
CaDPA slowly in the absence of glycine. 346 
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 To further characterize the differences between these strains, we analyzed the amount of 347 
CaDPA present within the core of each strain and normalized this to the amount found in C. 348 
difficile UK1 (Figure 3H). For all strains, 1x105 spores were boiled in buffer, sedimented and the 349 
amount of CaDPA determined using Tb3+ fluorescence. As shown in Figure 3H, the amount of 350 
CaDPA present in C. difficile spores varied between strains (though only by approximately 2-351 
fold in the lowest DPA-containing strain, C. difficile DH1834).   352 
Germinant receptor levels vary between C. difficile strains. 353 
To begin to understand how different C. difficile isolates display different EC50 or 354 
inhibitor constant values for bile acids, we analyzed the abundance of CspB, CspC and SleC in 355 
purified C. difficile spores. Purified C. difficile spores were extracted with NuPAGE buffer, as 356 
described previously (37). We found that by boiling spores in NuPAGE buffer, the amount of 357 
remaining CspB, CspC or SleC in the NuPAGE insoluble fraction (containing unbroken spores) 358 
to be below the limit of detection. Known amounts of the recombinant CspC, CspB or SleC 359 
protein and spore extracts were separated by SDS-PAGE and detected using rabbit polyclonal 360 
antisera followed by Alexa Fluor® 555-conjugated donkey anti-rabbit IgG. The standard curves 361 
generated from the signals on each SDS-PAGE were linear (Figure 4). From the signal 362 
intensities of the extracted CspB (Figure 4A), CspC (Figure 4B) and SleC (Figure 4C), the 363 
volume loaded onto the SDS-PAGE, the molecular weights of each protein and the amount of 364 
spores extracted, we were able to determine the average abundance of each protein in a C. 365 
difficile spore (Table 2).  366 
The abundance of these proteins varied between C. difficile isolates. For example, C. 367 
difficile UK1 had approximately 2,000 CspC molecules per spore while C. difficile M68 had over 368 
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3,800. Interestingly, C. difficile CD2315 and C. difficile M120 had a very low abundance of 369 
CspB (435 and 633 molecules per spore, respectively). As described previously for C. 370 
perfringens, the average amount of SleC per spore was greater than that of both CspC and CspB 371 
but also varied between strains (Table 2) (41). 372 
Prior work has suggested that much of the OD change observed during spore germination 373 
is due to the release of CaDPA from the spore core (42). During C. difficile spore germination, 374 
this event is dependent on the hydrolysis of the spore cortex by SleC (27). Because SleC is 375 
deposited into the spore as a zymogen, SleC must be activated by CspB in order to stimulate 376 
germination. In our original model for bile acid mediated spore germination, CspB is activated 377 
by the CspC germinant receptor. Because the abundance of CspC varied between isolates, we 378 
determined if the maximum rate of spore germination correlated with the abundance of CspC. 379 
Thus, for each strain we calculated the maximum rate of germination from the germination 380 
curves used to calculate the EC50,TA (Table 3). Surprisingly, there was a slight trend for an 381 
inverse correlation of the abundance of CspC and rate (R2 = 0.32; Figure 5A), suggesting that 382 
CspC may have an inhibitory effect on spore germination.  383 
Because SleC-mediated cortex hydrolysis is required for CaDPA release during C. 384 
difficile spore germination, if the above trend is true we should observe a positive correlation 385 
between the ratio of SleC to CspC and germination rate (more SleC molecules to CspC 386 
molecules should result in an increased rate of germination). As shown in Figure 5B, we 387 
observed a strong correlation (R2 = 0.81) between SleC/CspC and germination rate, again 388 
suggesting that CspC has an inhibitory effect on spore germination.  389 
Discussion 390 
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 Spore germination is an important step in the lifecycle of any spore-forming organism. 391 
The metabolically dormant spores must sense when conditions again become favorable for 392 
growth and quickly respond to the germinants used by that bacterium. Germination in an 393 
environment unfavorable for growth could prevent the outgrowth of a vegetative cell from the 394 
germinated spore or prevent the vegetative growth of that bacterium. Thus the signals that 395 
stimulate germination (germinants) can vary between organisms depending on their growth 396 
niche. For example, C. difficile vegetative cells are not normally found growing outside of a host, 397 
thus it would be logical for C. difficile spores to respond to a molecule that is host-specific. In 398 
fact, C. difficile spore germination is activated by cholic acid-class bile acids (e.g., TA) and is 399 
inhibited by chenodeoxycholic acid-class bile acids (e.g., CDCA) (11, 14, 19, 23). Though 400 
essential, TA is not sufficient to stimulate C. difficile spore germination. Glycine is also required, 401 
presumably as a measure of the nutrient status of the surrounding environment (19, 43, 44). 402 
 Until recently, most of the studies on C. difficile spore germination have relied on 403 
identifying germinants and their interactions with bile acids, bile acid analogs, amino acids and 404 
amino acid analogs (11, 19, 23-25, 39, 45, 46). Only recently have the mechanisms of C. difficile 405 
spore germination been studied, largely due to breakthroughs in genetics (47-51). These 406 
breakthroughs allowed us to determine that the germination-specific, pseudoprotease, CspC, is 407 
the bile acid germinant receptor.  408 
 The germination-specific proteases have largely been studied in C. perfringens (41, 52-409 
54). In C. perfringens the CspA, CspB and CspC proteins are all catalytically active proteases 410 
that can cleave the cortex hydrolase, SleC, to an active form. In C. difficile, the cspB and cspA 411 
genes have been translationally fused and yield CspBA upon translation (26, 29). The CspBA 412 
protein undergoes interdomain processing by the YabG protease to generate CspB and CspA 413 
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(55). We proposed a model whereby activated CspC transmits the signal to the CspB protease 414 
which then activates SleC. In support of this model, we found that CaDPA release from the core 415 
is dependent on hydrolysis of the spore cortex (27).  416 
 If SleC activation occurs prior to CaDPA release from the spore core and if SleC-417 
mediated cortex hydrolysis is essential for germination to begin, all C. difficile strains should 418 
have the requirement for bile acids to initiate germination (unless some C. difficile strains 419 
germinate using yet another novel mechanism for spore germination). However, some C. difficile 420 
strains were reported to have no apparent requirement for TA-mediated germination or whose 421 
germination was not inhibited by CDCA (31). If germination in these strains was not influenced 422 
by bile acids, by what mechanism(s) were they germinating? 423 
 To characterize the germination phenotypes in these strains, we determined the the 424 
EC50,TA and inhibitor constant values for these strains and strains previously shown to be 425 
activated by TA and inhibited by CDCA. As suggested previously, the germination 426 
characteristics of these strains varied and did not correlate with ribotype (31). Importantly, 427 
though, we did observe that some strains have increased EC50,TA values while another had a 428 
reduced inhibitor constant for CDCA (Table 1). These strains’ increased potency towards TA 429 
could possibly explain previous observations (31). Spores derived from strains 5108111, 430 
DH1834, DH1858 and CD2315 were found previously to lose OD600 in rich medium in the 431 
absence of apparent TA (bile acids can be found in blood and, thus, animal products). Moreover, 432 
the authors found that germination of spores derived from strains 5108111, DH1834 and 433 
CD2315 was not inhibited by the CDCA anti-germinant. Importantly, those strains whose 434 
germination was not inhibited by CDCA had increased EC50,TA values. Because the prior work 435 
used only one concentration of TA and CDCA [0.1% (1.8 mM) and 2 mM, respectively], to test 436 
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the effects of CDCA as an inhibitor, it is likely that these strains’ increased EC50,TA overcame the 437 
inhibitory effect of CDCA (31). By quantifying the interactions between spores derived from 438 
these strains and TA /CDCA, we re-establish the importance of bile acids in promoting and 439 
inhibiting germination in these strains. 440 
 The differences in EC50,TA and inhibitor constants were not consistent between ribotypes. 441 
A growing body of evidence suggests that toxin production, sporulation and germination are not 442 
correlated with ribotype (30, 31, 56). In support of this observation, the calculated EC50,TA and 443 
inhibitor constant values were not attributed to specific substitutions within the CspB, CspA or 444 
CspC protein sequences and substitutions were ribotype-specific. Of the three proteins, CspB had 445 
the fewest substitutions. Because CspB is required to cleave pro-SleC, CspB is likely under 446 
evolutionary pressure to perform this function. Interestingly, CspC and CspA had 26 and 42 447 
substitutions, respectively. The many substitutions in CspA could suggest that of the Csp 448 
proteins, it is under the least amount of selective pressure. Though the role of CspA is unknown, 449 
the presence of CspA is important for controlling the levels of the germinant receptor, CspC 450 
(55). Only one strain, C. difficile CD2315, encoded an extra substitution in the CspC protein 451 
sequence that was not present in the other 078 ribotype, P317L. Curiously, C. difficile CD2315 is 452 
the only strain that germinated in buffered TA without the need for the glycine co-germinant 453 
(though glycine still enhanced germination in this strain suggesting the spore still responds to 454 
glycine). Clearly, more studies are needed to characterize the effects of these substitutions on C. 455 
difficile spore germination. 456 
 We further characterized these strains by determining the average per spore abundance of 457 
CspB, CspC and SleC (we could not generate a standard curve for CspA – it is insoluble when 458 
recombinantly expressed). As expected, the number of molecules per spore varied between 459 
 o
n
 Septem
ber 12, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
22 
 
isolates and did not correlate with ribotype (Table 2). The abundance of each of these proteins is 460 
greater than the amount of germinant receptors found in B. subtilis (57). However, the increased 461 
abundance of CspB and SleC found in the C. difficile spore, compared to the B. subtilis 462 
germinant receptors, is consistent with a recent publication describing the amount of these 463 
proteins in C. perfringens (41). And, as seen in C. perfringens, the amount of SleC was greater 464 
than the amount of CspB. The amount of CspC in the C. difficile spore was similar to CspB but 465 
varied (Table 2). 466 
 By determining the kinetics of spore germination for several C. difficile strains, we were 467 
positioned to determine if the kinetic properties of germination could be attributed to differences 468 
in the abundance of germination-specific proteins (CspB, CspC and SleC). In B. subtilis, 469 
overexpression of the GerAA germinant receptor results in an increase in the germination rate (as 470 
measured by the decrease in OD600 and by the release of CaDPA) (58). Prior work has shown 471 
that much of the OD600 change that occurs during germination is due to the release of CaDPA 472 
from the spore core (42). In C. difficile, CaDPA release is dependent on SleC-mediated cortex 473 
hydrolysis (27, 28). Thus, we hypothesized that an increased abundance of SleC would correlate 474 
with an increased rate of germination. Also, because SleC activity is dependent on activation by 475 
CspB, an increased abundance of CspB could result in more active SleC during germination and, 476 
thus, an increased rate of germination. However, we did not observe any correlation between the 477 
rate of spore germination and the abundance of the SleC hydrolase or CspB protease. One 478 
possible explanation for this could be that the abundance of both SleC and CspB in the C. 479 
difficile spores are far past saturating levels and any alteration in the observed levels would have 480 
minimal effects on the rate of germination. Surprisingly, we observed a trend for an inversed 481 
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correlation between the rate of germination and CspC abundance [the more CspC 482 
molecules/spore the slower the rate of germination (Figure 5A)]. 483 
 If this correlation is true, we predicted that more SleC molecules would be needed to 484 
overcome the potential inhibitory effect CspC would have on C. difficile spore germination. 485 
Indeed, we observed a strong correlation between SleC/CspC and the rate of germination (Figure 486 
5B; R2 = 0.81). These results suggest that, instead of the activator function we originally 487 
hypothesized, that CspC may be acting to inhibit C. difficile spore germination. 488 
 If true, how would CspC function during germination? Our prior genetic data suggests 489 
that CspC transmits the bile acid signal to begin the germination process, though the mechanism 490 
is unclear (13). Recently, GerS was identified and recognized to play a role during germination 491 
(59). GerS is a protein that is anchored to the inner leaflet of the outer spore membrane (though 492 
the lipidation of GerS is not required for it to function during germination). Interestingly, C. 493 
difficile gerS- strains have a defect in germination but still cleave SleC to the active hydrolase 494 
form. This suggested that SleC activity, somehow, is inhibited in this strain (59). Based on the 495 
correlation between CspC and SleC abundance and our kinetic data, we hypothesize that CspC 496 
activates CspB but inhibits SleC activity in the absence of GerS. Investigating the biochemistry 497 
of this germinant receptor complex could lead to a greater understanding of the mechanism of 498 
initiating C. difficile spore germination. 499 
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Table 1. Quantifying the interaction of C. difficile spores with bile acids. 510 
 511 
 512 
The apparent EC50,TA and inhibitor constant values were calculated from the germination curves 513 
as described previously (11, 25, 32).  514 
aInhibitor Constant= [inhibitor]/[(EC50,TA with inhibitor)/((EC50,TA without inhibitor) – 1)] 515 
bInhibition ratio = Inhibitor Constant / EC50,TA 516 
* For statistical comparisons, the EC50,TA values were compared to each other and the inhibitor 517 
constant values were compared to each other as described in the materials and methods. p-val < 518 
0.01 519 
 520 
Table 2. Number of Csp molecules per C. difficile spore 521 
Strain Average CspB Average CspC Average SleC Ratio 
SleC/CspC 
Strain Apparent 
EC50,TA (mM) 
Inhibitor 
Constant (mM)a 
Inhibition ratiob 
UK1 2.95 ± 0.23 0.21 ± 0.07 14.0 
5108111 0.76 ± 0.14 * 0.52 ± 0.03 * 1.5 
CD2315 0.42 ± 0.07 * 0.18 ± 0.03 2.3 
DH1834 3.00 ± 0.45 0.21 ± 0.08 14.3 
DH1858 3.03 ± 0.36 0.29 ± 0.07 10.4 
M68 3.35 ± 0.39 0.12 ± 0.02 27.9 
M120 2.37 ± 0.14  0.17 ± 0.02 13.9 
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UK1 1,394 ± 426 2,141 ± 164 46,090 ± 5,089 21.5 
5108111 3081 ± 154 2,304 ± 209 31,614 ± 3,497 13.7 
CD2315 435 ± 86 1,689 ± 137 41,239 ± 1,832 24.4 
DH1834 1,178 ± 120 3,155 ± 139 37,876 ± 2,027 12.0 
DH1858 1,572 ± 60 1,435 ± 154 37,557 ± 827 26.2 
M68 1,284 ± 160 3,836 ± 541 46,685 ± 3,507 12.2 
M120 633 ± 36 2,423 ± 203 29,473 ± 1,724 12.2 
 522 
The average number of molecules CspB, CspC and SleC were calculated as described in Figure 523 
4. The numbers represent the averages of three independent extractions ± the standard deviation 524 
from the mean.  525 
 526 
Table 3. Rates of C. difficile spore germination 527 
Strain Germination rate (OD x 10-3 / sec) 
UK1 1.47 ± 0.092 
5108111 1.30 ± 0.082 
CD2315 1.67 ± 0.047 
DH1834 1.23 ± 0.047 
DH1858 1.62 ± 0.11 
M68 1.35 ± 0.054 
M120 1.04 ± 0.043 
 528 
The rates of spore germination were calculated using the linear portion of the germination 529 
curves, as described previously (11, 25, 32). Values represent the mean from three independent 530 
experiments ± the standard deviation from the mean. 531 
 532 
 533 
Figure 1. Bile acid-mediated spore germination of several C. difficile strains. Purified C. 534 
difficile spores were suspended in BHIS medium alone (●) or medium supplemented with 2 mM 535 
(■), 5 mM (▲), 10 mM (▼), 20 mM (♦) or 50 mM (○) TA. Germination was monitored at OD600 536 
as described previously. (A) C. difficile UK1, (B) C. difficile 5108111, (C) C. difficile CD2315, 537 
(D) C. difficile DH1834, (E) C. difficile DH1858, (F) C. difficile M68, (G) C. difficile M120. A 538 
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representative sample from 3 independent experiments is shown. For transparency, all plots are 539 
shown in Figure S1. 540 
 541 
Figure 2. Chenodeoxycholic acid inhibits C. difficile spore germination. Purified C. difficile 542 
spores were suspended in BHIS medium supplemented with 1 mM CDCA (●) or medium 543 
supplemented with 2 mM (■), 5 mM (▲), 10 mM (▼), 20 mM (♦) or 50 mM (○) TA and 1 mM 544 
CDCA. Germination was monitored at OD600 as described previously. (A) C. difficile UK1, (B) 545 
C. difficile 5108111, (C) C. difficile CD2315, (D) C. difficile DH1834, (E) C. difficile DH1858, 546 
(F) C. difficile M68, (G) C. difficile M120. A representative sample from 3 independent 547 
experiments is shown. For transparency, all plots are shown in Figure S3. 548 
 549 
Figure 3. DPA release by several C. difficile strains. Purified C. difficile spores were 550 
suspended in HEPES buffer (●) or buffer supplemented with 10 mM TA (■), 100 mM glycine 551 
(▲) or 10 mM TA and 100 mM glycine (▼). DPA release during spore germination was 552 
monitored using Tb3+ fluorescence, as described previously. (A) C. difficile UK1, (B) C. difficile 553 
5108111, (C) C. difficile CD2315, (D) C. difficile DH1834, (E) C. difficile DH1858, (F) C. 554 
difficile M68, (G) C. difficile M120. (H) Purified C. difficile spores were suspended in buffer and 555 
incubated at 100 °C for 30 minutes. Total DPA content was normalized to the amount of DPA 556 
found in C. difficile UK1. All data represent the average of three independent experiments and 557 
error bars represent the standard deviation from the mean. 558 
 559 
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Figure 4. Quantifying the abundance of CspB, CspC and SleC in C. difficile spores. 1x109 560 
C. difficile UK1 spores were extracted with NuPAGE buffer, as described previously. NuPAGE-561 
soluble protein from three independent extracts was loaded onto a 10% SDS polyacrylamide gel 562 
along with recombinantly expressed and purified protein, as a protein standard. Samples were 563 
separated and detected as described in the materials and methods. Signal intensities were 564 
quantified and used to generate a standard curve for (A) CspB, (B) CspC and (C) SleC. Signal 565 
intensities in the spore extract samples were quantified and the generated standard curve was 566 
used to quantify the abundance of the specified proteins in the spore extracts. Independent 567 
standard curves were generated for each strain and the results of the quantification can be found 568 
in Table 2. ** full length pre-pro-SleC. * pro-SleC. 569 
 570 
Figure 5. Correlating the abundance of C. difficile proteins with the kinetics of spore 571 
germination. (A) The calculated average per spore abundance of CspC was plotted vs. the 572 
calculated rates of spore germination. (B) The ratio of SleC to CspC was plotted vs. the 573 
calculated rates of spore germination. For all plots, GraphPad Prism was used to generate the 574 
linear fit to the curves and the listed R2 values represent the fit of the curve to the data. 575 
 576 
  577 
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